Violeta Arsenescu, Razvan Arsenescu, Madhura Parulkar, Michael Karounos, Xuan Zhang, Nicki Baker, Lisa A Cassis
Index: Toxicol. Appl. Pharmacol. 257(1) , 148-54, (2011)
Full Text: HTML
Infusion of angiotensin II (AngII) to hyperlipidemic mice augments atherosclerosis and causes formation of abdominal aortic aneurysms (AAAs). Each of these AngII-induced vascular pathologies exhibit pronounced inflammation. Previous studies demonstrated that coplanar polychlorinated biphenyls (PCBs) promote inflammation in endothelial cells and adipocytes, two cell types implicated in AngII-induced vascular pathologies. The purpose of this study was to test the hypothesis that administration of PCB77 to male apolipoprotein E (ApoE) -/- mice promotes AngII-induced atherosclerosis and AAA formation. Male ApoE-/- mice were administered vehicle or PCB77 (49 mg/kg, i.p.) during week 1 and 4 (2 divided doses/week) of AngII infusion. Body weights and total serum cholesterol concentrations were not influenced by administration of PCB77. Systolic blood pressure was increased in AngII-infused mice administered PCB77 compared to vehicle (156±6 vs 137±5 mmHg, respectively). The percentage of aortic arch covered by atherosclerotic lesions was increased in AngII-infused mice administered PCB77 compared to vehicle (2.0±0.4 vs 0.9±0.1%, respectively). Lumen diameters of abdominal aortas determined by in vivo ultrasound and external diameters of excised suprarenal aortas were increased in AngII-infused mice administered PCB77 compared to vehicle. In addition, AAA incidence increased from 47 to 85% in AngII-infused mice administered PCB77. Adipose tissue in close proximity to AAAs from mice administered PCB77 exhibited increased mRNA abundance of proinflammatory cytokines and elevated expression of components of the renin-angiotensin system (angiotensinogen, angiotensin type 1a receptor (AT1aR)). These results demonstrate that PCB77 augments AngII-induced atherosclerosis and AAA formation.Copyright © 2011 Elsevier Inc. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
3,3',4,4'-Tetrachlorobiphenyl
CAS:32598-13-3 |
C12H6Cl4 |
Biotransformation of 2,2',5,5'-tetrachlorobiphenyl (PCB 52) ...
2011-05-16 [Chem. Res. Toxicol. 24(5) , 718-25, (2011)] |
Differential sensitivity of CYP1A to 3,3',4',4-tetrachlorobi...
1998-05-01 [Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 152(1) , 42-50, (2010)] |
Lack of CYP1A responsiveness in species inhabiting chronical...
2013-03-01 [Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 157(2) , 212-9, (2013)] |
Identification and mRNA expression of pi-class glutathione S...
2012-03-01 [Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 155(2) , 300-6, (2012)] |
Increased proliferative effect of organochlorine compounds o...
2012-06-01 [Mol. Cell Biochem. 365(1-2) , 275-8, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved